SCHEMBL24264255

SCHEMBL24264255

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc(-c5ccc6c(c5)oc5ccccc56)cc34)nc(-c3cccc4c3sc3ccccc34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 7/20 0.43
ALOX5 P09917 1/20 0.41
PLA2G2A P14555 2/20 0.35
PLA2G4A P47712 2/20 0.35
PLA2G10 O15496 1/20 0.35
LIMK1 P53667 2/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
HCRTR1 O43613 1/20 0.33
CHEK2 O96017 1/20 0.33
BRD4 O60885 1/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33
KCNH2 Q12809 1/20 0.33
BRDT Q58F21 1/20 0.33
MAPT P10636 2/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24264112 1.00 PRKDC (0.43) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL25627449 0.98 PRKDC (0.43) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL24217295 0.98 PRKDC (0.43) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL25627155 0.98 PRKDC (0.43) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL25627444 0.98 PRKDC (0.43) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL25019311 0.98 PRKDC (0.44) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL22330037 0.98 PRKDC (0.44) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL21784867 0.97 PRKDC (0.41) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL21756052 0.97 PRKDC (0.42) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL24217177 0.97 PRKDC (0.42) PRKDCALOX5PLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, TRPC1, CYP1A1 PRKDC 4335/4885ALOX5 1152/4885PLA2G2A 4009/4885
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, TRPC1, CYP1A1 PRKDC 4335/4885ALOX5 1152/4885PLA2G2A 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.